Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis

Despite the progress of the past two decades, the cause of Alzheimer's disease (AD) and effective treatments against it remain elusive. The hypothesis that amyloid-β (Aβ) peptides are the primary causative agents of AD retains significant support among researchers. Nonetheless, a growing body of evidence shows that Aβ peptides are unlikely to be the sole factor in AD etiology. Evidence that Aβ/amyloid-independent factors, including the actions of AD-related genes, also contribute significantly to AD pathogenesis was presented in a symposium at the 2010 Annual Meeting of the Society for Neuroscience. Here we summarize the studies showing how amyloid-independent mechanisms cause defective endo-lysosomal trafficking, altered intracellular signaling cascades, or impaired neurotransmitter release and contribute to synaptic dysfunction and/or neurodegeneration, leading to dementia in AD. A view of AD pathogenesis that encompasses both the amyloid-dependent and -independent mechanisms will help fill the gaps in our knowledge and reconcile the findings that cannot be explained solely by the amyloid hypothesis.

[1]  Richard D. Kim,et al.  Reduced β-Amyloid Production and Increased Inflammatory Responses in Presenilin Conditional Knock-out Mice* , 2004, Journal of Biological Chemistry.

[2]  A. Cuervo Autophagy and aging: keeping that old broom working. , 2008, Trends in genetics : TIG.

[3]  C. Chu,et al.  Review: Autophagy and neurodegeneration: survival at a cost? , 2010, Neuropathology and applied neurobiology.

[4]  J. Schröder,et al.  Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42 , 2005, Neurobiology of Aging.

[5]  Xinran Liu,et al.  Characterization of Age-Dependent and Progressive Cortical Neuronal Degeneration in Presenilin Conditional Mutant Mice , 2010, PloS one.

[6]  E. Kandel,et al.  APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout Mice , 2001, Neuron.

[7]  Li-Huei Tsai,et al.  A decade of CDK5 , 2001, Nature Reviews Molecular Cell Biology.

[8]  Li-Huei Tsai,et al.  Aberrant Cdk5 Activation by p25 Triggers Pathological Events Leading to Neurodegeneration and Neurofibrillary Tangles , 2003, Neuron.

[9]  Y. Suh,et al.  Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl‐terminal fragment of Alzheimer's APP in mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Deepak Srinivasan,et al.  Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. , 2010, Human molecular genetics.

[11]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.

[12]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[13]  R. Nixon,et al.  Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.

[14]  R. Nixon,et al.  Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. , 2008, The American journal of pathology.

[15]  B. Strooper,et al.  Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms , 2006, Journal of neurochemistry.

[16]  C. Epstein,et al.  App Gene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome , 2003, The Journal of Neuroscience.

[17]  L. Gan,et al.  Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease , 2008, Neuron.

[18]  B. Yankner,et al.  Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Morris,et al.  Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.

[20]  J. Shioi,et al.  A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. , 2003, Cell.

[21]  L. Baki,et al.  Wild-Type But Not FAD Mutant Presenilin-1 Prevents Neuronal Degeneration by Promoting Phosphatidylinositol 3-Kinase Neuroprotective Signaling , 2008, The Journal of Neuroscience.

[22]  D. Bredesen,et al.  Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain , 2011, Neurobiology of Aging.

[23]  D. Kang,et al.  Presenilins Mediate Phosphatidylinositol 3-Kinase/AKT and ERK Activation via Select Signaling Receptors , 2005, Journal of Biological Chemistry.

[24]  E. Kandel,et al.  Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration , 2004, Neuron.

[25]  A. Cuervo,et al.  Autophagy gone awry in neurodegenerative diseases , 2010, Nature Neuroscience.

[26]  Richard D. Kim,et al.  Reduced beta-amyloid production and increased inflammatory responses in presenilin conditional knock-out mice. , 2004, The Journal of biological chemistry.

[27]  G. Serban,et al.  Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB‐induced Src phosphorylation and signaling , 2006, The EMBO journal.

[28]  Nick C Fox,et al.  Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.

[29]  R. Terry,et al.  Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia , 1967, Acta Neuropathologica.

[30]  M. Arbel,et al.  Inhibition of amyloid precursor protein processing by beta-secretase through site-directed antibodies. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Stiegler,et al.  The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. , 1998, Cancer research.

[32]  S. Pimplikar,et al.  The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  M. Mercken,et al.  Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein , 2002, The Journal of Biological Chemistry.

[34]  T. Ohm,et al.  Cholesterol and Tau Protein - Findings in Alzheimer’s and Niemann Pick C’s Disease , 2003, Pharmacopsychiatry.

[35]  J. Taylor,et al.  The Role of Autophagy in Age-Related Neurodegeneration , 2007, Neurosignals.

[36]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[37]  Ralph A. Nixon,et al.  Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[38]  S. Pimplikar,et al.  Reassessing the amyloid cascade hypothesis of Alzheimer's disease. , 2009, The international journal of biochemistry & cell biology.

[39]  R. J. Kelleher,et al.  Indirect Regulation of Presenilins in CREB-mediated Transcription* , 2009, Journal of Biological Chemistry.

[40]  D. Westaway,et al.  Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.

[41]  A. Georgakopoulos,et al.  Peptide EphB2/CTF2 Generated by the γ-Secretase Processing of EphB2 Receptor Promotes Tyrosine Phosphorylation and Cell Surface Localization of N-Methyl-d-aspartate Receptors* , 2009, The Journal of Biological Chemistry.

[42]  L. Polito,et al.  Early-Onset Alzheimer Disease in an Italian Family With Presenilin-1 Double Mutation E318G and G394V , 2008, Alzheimer disease and associated disorders.

[43]  N. Robakis An Alzheimer's disease hypothesis based on transcriptional dysregulation , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[44]  A. Verma,et al.  Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study , 2008 .

[45]  S. Pimplikar,et al.  APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation , 2010, PloS one.

[46]  Petti T. Pang,et al.  Opposing Roles of Transient and Prolonged Expression of p25 in Synaptic Plasticity and Hippocampus-Dependent Memory , 2005, Neuron.

[47]  David S. Park,et al.  Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease , 2007, Neuron.

[48]  L. Mucke,et al.  Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease , 2006, Neuron.

[49]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[50]  M. Scarpa,et al.  Pathophysiology of neuropathic lysosomal storage disorders , 2010, Journal of Inherited Metabolic Disease.

[51]  Jie Shen,et al.  Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease. , 2006, Trends in pharmacological sciences.

[52]  P. Marambaud,et al.  Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation , 2004, Genes, brain, and behavior.

[53]  R. J. Kelleher,et al.  A Presenilin-1 Mutation Identified in Familial Alzheimer Disease with Cotton Wool Plaques Causes a Nearly Complete Loss of γ-Secretase Activity* , 2010, The Journal of Biological Chemistry.

[54]  K. Wang,et al.  Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. , 2000, Biochemical and biophysical research communications.

[55]  Kerry A. Mullaney,et al.  Alzheimer’s-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition , 2009, Proceedings of the National Academy of Sciences.

[56]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[57]  Marc Tessier-Lavigne,et al.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases , 2009, Nature.

[58]  D L Price,et al.  Alzheimer's disease: genetic studies and transgenic models. , 1998, Annual review of genetics.

[59]  M. Bothwell,et al.  Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment. , 2005, Journal of neurochemistry.

[60]  L. Baki,et al.  PS1 activates PI3K thus inhibiting GSK‐3 activity and tau overphosphorylation: effects of FAD mutations , 2004, The EMBO journal.

[61]  T. Südhof,et al.  Presenilins are Essential for Regulating Neurotransmitter Release , 2009, Nature.

[62]  T. Deerinck,et al.  Re‐Evaluation of the Structural Organization of Neuritic Plaques in Alzheimer's Disease , 1993 .

[63]  P. L. Peng,et al.  Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity , 2008, Neuron.

[64]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[65]  Thomas C. Südhof,et al.  A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60 , 2001, Science.

[66]  R. Neve,et al.  Transgenic mice expressing APP-C100 in the brain , 1996, Neurobiology of Aging.

[67]  R. J. Kelleher,et al.  The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.

[68]  R. Neve,et al.  Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.

[69]  S. Pimplikar,et al.  Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain , 2005, The Journal of cell biology.

[70]  Y. Suh,et al.  Carboxyl‐terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  Ahmad Salehi,et al.  Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration , 2006, Neuron.

[72]  R. Nixon,et al.  Neurodegenerative lysosomal disorders: A continuum from development to late age , 2008, Autophagy.

[73]  Nektarios Tavernarakis,et al.  Can autophagy promote longevity? , 2010, Nature Cell Biology.

[74]  L. Kudo,et al.  Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy , 2009, Proceedings of the National Academy of Sciences.

[75]  K. Ishiguro,et al.  Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25* , 2000, The Journal of Biological Chemistry.

[76]  T. Südhof,et al.  A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. , 2001, Science.

[77]  M. Shapiro,et al.  Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein , 1997, Nature.

[78]  F. Pasquier,et al.  A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk , 2008, Cell.

[79]  L. Tjernberg,et al.  Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease , 2005, The Journal of cell biology.

[80]  C. Glabe Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer’s disease , 2001, Journal of Molecular Neuroscience.

[81]  B. Strooper,et al.  Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.

[82]  T. Südhof,et al.  Conditional Forebrain Inactivation of Nicastrin Causes Progressive Memory Impairment and Age-Related Neurodegeneration , 2009, The Journal of Neuroscience.

[83]  M. Bothwell,et al.  Familial Alzheimer's disease mutations inhibit γ‐secretase‐mediated liberation of β‐amyloid precursor protein carboxy‐terminal fragment , 2005 .

[84]  S. Paik,et al.  Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein , 2006, Neurobiology of Disease.

[85]  Brian David Dynlacht,et al.  E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. , 2002, Genes & development.

[86]  A. Georgakopoulos,et al.  Ligand Binding and Calcium Influx Induce Distinct Ectodomain/γ-Secretase-processing Pathways of EphB2 Receptor* , 2007, Journal of Biological Chemistry.

[87]  Jie Shen,et al.  Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases , 2010, Neurodegenerative Diseases.

[88]  R. Neve,et al.  Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression , 2010, Biological Psychiatry.

[89]  J. Shioi,et al.  A CBP Binding Transcriptional Repressor Produced by the PS1/ϵ-Cleavage of N-Cadherin Is Inhibited by PS1 FAD Mutations , 2003, Cell.

[90]  Jayanta Debnath,et al.  Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease , 2010, PloS one.

[91]  Bryan Maloney,et al.  Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing , 2008, Neuron.

[92]  N. Robakis Mechanisms of AD neurodegeneration may be independent of Aβ and its derivatives , 2011, Neurobiology of Aging.

[93]  Yong Shen,et al.  Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain , 2009, Proceedings of the National Academy of Sciences.

[94]  H. Rusinek,et al.  Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[95]  Ralph A. Nixon,et al.  Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study , 2005, Journal of neuropathology and experimental neurology.

[96]  Jerry H. Wang,et al.  Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors , 2003, Nature Neuroscience.

[97]  D. Rubinsztein,et al.  Autophagy, a guardian against neurodegeneration , 2010, Seminars in cell & developmental biology.

[98]  J. Bibb Faculty Opinions recommendation of Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. , 2008 .

[99]  T. Südhof,et al.  Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction , 2010, Journal of neurochemistry.

[100]  D. O’Carroll,et al.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.

[101]  Z. Kouchi,et al.  FAD mutants unable to increase neurotoxic Aβ 42 suggest that mutation effects on neurodegeneration may be independent of effects on Aβ , 2006, Journal of neurochemistry.